Alloy: Building a better toolbox for biologics developers 

Four-year-old Alloy is acting on its vision to become an infrastructure partner to biologic drug developers by collecting an arsenal of tools and resources, starting with an in-licensed transgenic mouse platform for antibody discovery.

Founded and backed initially by serial entrepreneur Errik Anderson, a co-founder and former COO of antibody company Adimab LLC, the start-up has quietly assembled a roster of more than 70 partners since launching commercially in early 2019...